MedPage Today (11/29, Firth) reports, “Antipsychotic medication-related deaths were rare among children, but young adults on higher doses had a significantly increased risk of death, according to a U.S. national retrospective cohort study of Medicaid patients.” In the study, “those ages 18 to 24 had increased risk of death with current use of second-generation antipsychotic agents in daily doses of greater than 100-mg chlorpromazine equivalents compared with control medications including antidepressants and mood stabilizers, reported” researchers in JAMA Psychiatry.
Related Links:
— MedPage Today (requires login and subscription)